Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study

Angella Musiimenta, Wilson Tumuhimbise, Aaron T Mugaba, Conrad Muzoora, Mari Armstrong-Hough, David Bangsberg, J Lucian Davis, Jessica E Haberer, Angella Musiimenta, Wilson Tumuhimbise, Aaron T Mugaba, Conrad Muzoora, Mari Armstrong-Hough, David Bangsberg, J Lucian Davis, Jessica E Haberer

Abstract

Background: Effective administration of tuberculosis therapy remains challenging. The recommended strategy of direct observed therapy is challenging and its implementation has been limited in many settings. Digital adherence technologies could be promising patient-centered strategies for monitoring adherence. However, few quality studies have assessed patients' experiences with these technologies.

Objective: To explore TB patients' perceptions of a digital adherence intervention composed of a digital adherence monitor and SMS texts.

Methods: We purposively sampled TB patients who owned phones, had been taking TB medication for at least a month, and were receiving their treatment from Mbarara Regional Referral Hospital. We interviewed 35 TB patients to elicit information on perceptions of the proposed intervention which electronically monitors how they take their medication, and sends SMS reminders to patients to help them take their medications, as well as send SMS notifications to patients' social supporters to provide the patient with assistance if possible. We inductively analyzed data using content analysis to derive categories describing how participants perceived the intervention.

Results: Participants anticipated that the intervention would enhance medication adherence by reminding them to take medication, and helping in the management of complicated regimen. Participants felt that monitoring adherence could enable them to demonstrate their commitment to adherence. Participants expressed concerns about not seeing the SMS on time and unintended TB status disclosure.

Conclusion: Digital adherence technologies may provide acceptable alternative approaches to monitoring TB medication, especially in settings where DOT is difficult to implement.

Keywords: Digital adherence technologies; Forgetfulness; Habit formation; Medication adherence; Real-time monitoring; SMS reminders; Tuberculosis.

Conflict of interest statement

None.

© 2019 The Authors.

Figures

Fig. 1
Fig. 1
The Wisepill device.

References

    1. Horsburgh C.R.J., Barry C.E., III, Lange C. Treatment of tuberculosis. N Engl J Med. 2015;373(22):2149–2160.
    1. Adane A.A., Alene K.A., Koye D.N., Zeleke B.M. Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in Northwest Ethiopia. PLoS One. 2013;8(11):e78791.
    1. World Health Organization. Global tuberculosis control: WHO report 2000, in Global tuberculosis control: WHO report 2000.
    1. Alipanah N., Jarlsberg L., Miller C., Linh N.N., Falzon D., Jaramillo E. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7)
    1. Pasipanodya J.G., Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infecti Dis. 2013;57(1):21–31.
    1. O'Donnell M.R., Daftary A., Frick M., Hirsch-Moverman Y., Amico K.R., Senthilingam M. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2016;20(4):430–434.
    1. Tanimura T., Jaramillo E., Weil D., Raviglione M., Lonnroth K. Financial burden for tuberculosis patients in low-and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763–1775.
    1. Lei X., Huang K., Liu Q., Jie Y., Tang S. Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study. Infect Dis Poverty. 2016;5(1):38.
    1. World Health Organization. Guidelines for the treatment of drug-susceptible tuberculosis and patient care. 2017.
    1. Subbaraman R., de Mondesert L., Musiimenta A., Pai M., Mayer K.H., Thomas B.E. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Global health. 2018;3(5)
    1. International Telecommunication Union . 2016. Key global telecom indicators for the world telecommunication service sector. [cited 2017 17th Oct]. Available from:
    1. Ggita J., Ojok C., Meyer A.J., Farr K., Shete P.B., Ochom E. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. Int J Tuberc Lung Dis. 2018;22(5):530–536.
    1. Haberer J.E., Musiimenta A., Atukunda E.C., Musinguzi N., Wyatt M.A., Ware N.C. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30(8):1295.
    1. Sabin L.L., DeSilva M.B., Gill C., Li Z., Vian T., Wubin X. Improving adherence to antiretroviral therapy with triggered real time text message reminders: the China through technology study (CATS) J Acquir Immune Defic Syndr. 2015;69(5):551.
    1. World Health Organization . 2016. Global tuberculosis report 2016.
    1. Hsieh H., Shannon S.E. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
    1. Liu X., Lewis J.J., Zhang H., Lu W., Zhang S., Zheng G. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9)
    1. Mohammed S., Glennerster R., Khan A.J. Impact of a daily SMS medication reminder system on tuberculosis treatment outcomes: a randomized controlled trial. PLoS ONE. 2016;11(11)
    1. Albino S., Tabb K.M., Requena D., Egoavil M., Pineros-Leano M.F., Zunt J.R. Perceptions and acceptability of short message services technology to improve treatment adherence amongst tuberculosis patients in Peru: a Focus Group Study. PLoS ONE. 2014;9(5):e95770.
    1. Hermans S.M., Elbireer S., Tibakabikoba H., Hoefman B.J., Manabe Y.C. Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda. Patient Prefer Adherence. 2017;11:1479.
    1. Ware N.C., Pisarski E.E., Tam M., Wyatt M.A., Atukunda E., Musiimenta A. The meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30(8):1287.
    1. Musiimenta A., Atukunda E.C., Tumuhimbise W., Haberer J.E. Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda. AIDS Care. 2018:1–8.
    1. Ware N.C., Idoko J., Kaaya S., Biraro I.A., Wyatt M.A., Agbaji O. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1)
    1. Musiimenta A., Atukunda E.C., Tumuhimbise W., Pisarski E.E., Tam M., Wyatt M.A. Acceptability and feasibility of real-time antiretroviral therapy adherence interventions in rural Uganda: mixed-method pilot randomized controlled trial. JMIR Mhealth Uhealth. 2018;6(5)
    1. Katz I.T., Ryu A.E., Onuegbu A.G., Psaros C., Weiser S.D., Bangsberg D.R. Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis. J Int AIDS Soc. 2013;16:18640.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel